Receptor dimerization is not a factor in the signalling activity of a transforming variant epidermal growth factor receptor (EGFRvIII)

Charleen T. Chu, Keith D. Everiss, Carol J. Wikstrand, Surinder K. Batra, Hsing Jien Kung, Darell D. Bigner

Research output: Contribution to journalArticle

150 Citations (Scopus)

Abstract

The type-III deletion variant of the epidermal growth factor receptor (EGFRvIII) is frequently found in glioblastomas and other malignant human tumours. Although EGFRvIII confers ligand-independent oncogenic transformation of cell lines, the mechanism by which it promotes aberrant cellular proliferation is unknown. Using cell lines expressing comparable numbers of either wild-type receptor (EGFRwt) or EGFRvIII, we compared several parameters of receptor activation: dimerization, tyrosine phosphorylation and activation of intracellular signalling proteins. Like activated EGFRwt, EGFRvIII was phosphorylated and bound constitutively to the Shc adapter protein. Indeed, EGFRvIII-associated Shc had a higher phosphotyrosine content than Shc associated with stimulated EGFRwt. EGFRwt dimerized in response to either EGF or transforming growth factor α. Higher cross-linker concentrations and incubation at higher temperatures (37°C) allowed detection of EGFRwt dimers even in the absence of exogenous ligand. In contrast, EGFRvIII failed to dimerize under any conditions studied. Moreover, neither mitogen-activated protein kinase nor phospholipase Cγ were phosphorylated in EGFRvIII-expressing cells. We conclude that the deletion of 267 amino acids from the 621-amino-acid N-terminal domain of EGFR does not result simply in a constitutively activated receptor, but alters the spectrum of signalling cascades utilized. Furthermore the ligand-independent transforming activity of EGFRvIII is independent of receptor dimerization.

Original languageEnglish
Pages (from-to)855-861
Number of pages7
JournalBiochemical Journal
Volume324
Issue number3
DOIs
Publication statusPublished - Jun 15 1997
Externally publishedYes

Fingerprint

Dimerization
Epidermal Growth Factor Receptor
Ligands
Intracellular Signaling Peptides and Proteins
Chemical activation
Cells
Amino Acids
Cell Line
Phosphotyrosine
Phosphorylation
epidermal growth factor receptor VIII
Transforming Growth Factors
Type C Phospholipases
Glioblastoma
Mitogen-Activated Protein Kinases
Epidermal Growth Factor
Dimers
Tyrosine
Tumors
Cell Proliferation

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Receptor dimerization is not a factor in the signalling activity of a transforming variant epidermal growth factor receptor (EGFRvIII). / Chu, Charleen T.; Everiss, Keith D.; Wikstrand, Carol J.; Batra, Surinder K.; Kung, Hsing Jien; Bigner, Darell D.

In: Biochemical Journal, Vol. 324, No. 3, 15.06.1997, p. 855-861.

Research output: Contribution to journalArticle

Chu, Charleen T. ; Everiss, Keith D. ; Wikstrand, Carol J. ; Batra, Surinder K. ; Kung, Hsing Jien ; Bigner, Darell D. / Receptor dimerization is not a factor in the signalling activity of a transforming variant epidermal growth factor receptor (EGFRvIII). In: Biochemical Journal. 1997 ; Vol. 324, No. 3. pp. 855-861.
@article{3f188d33011e49fdaea5204ea6a74848,
title = "Receptor dimerization is not a factor in the signalling activity of a transforming variant epidermal growth factor receptor (EGFRvIII)",
abstract = "The type-III deletion variant of the epidermal growth factor receptor (EGFRvIII) is frequently found in glioblastomas and other malignant human tumours. Although EGFRvIII confers ligand-independent oncogenic transformation of cell lines, the mechanism by which it promotes aberrant cellular proliferation is unknown. Using cell lines expressing comparable numbers of either wild-type receptor (EGFRwt) or EGFRvIII, we compared several parameters of receptor activation: dimerization, tyrosine phosphorylation and activation of intracellular signalling proteins. Like activated EGFRwt, EGFRvIII was phosphorylated and bound constitutively to the Shc adapter protein. Indeed, EGFRvIII-associated Shc had a higher phosphotyrosine content than Shc associated with stimulated EGFRwt. EGFRwt dimerized in response to either EGF or transforming growth factor α. Higher cross-linker concentrations and incubation at higher temperatures (37°C) allowed detection of EGFRwt dimers even in the absence of exogenous ligand. In contrast, EGFRvIII failed to dimerize under any conditions studied. Moreover, neither mitogen-activated protein kinase nor phospholipase Cγ were phosphorylated in EGFRvIII-expressing cells. We conclude that the deletion of 267 amino acids from the 621-amino-acid N-terminal domain of EGFR does not result simply in a constitutively activated receptor, but alters the spectrum of signalling cascades utilized. Furthermore the ligand-independent transforming activity of EGFRvIII is independent of receptor dimerization.",
author = "Chu, {Charleen T.} and Everiss, {Keith D.} and Wikstrand, {Carol J.} and Batra, {Surinder K.} and Kung, {Hsing Jien} and Bigner, {Darell D.}",
year = "1997",
month = "6",
day = "15",
doi = "10.1042/bj3240855",
language = "English",
volume = "324",
pages = "855--861",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press Ltd.",
number = "3",

}

TY - JOUR

T1 - Receptor dimerization is not a factor in the signalling activity of a transforming variant epidermal growth factor receptor (EGFRvIII)

AU - Chu, Charleen T.

AU - Everiss, Keith D.

AU - Wikstrand, Carol J.

AU - Batra, Surinder K.

AU - Kung, Hsing Jien

AU - Bigner, Darell D.

PY - 1997/6/15

Y1 - 1997/6/15

N2 - The type-III deletion variant of the epidermal growth factor receptor (EGFRvIII) is frequently found in glioblastomas and other malignant human tumours. Although EGFRvIII confers ligand-independent oncogenic transformation of cell lines, the mechanism by which it promotes aberrant cellular proliferation is unknown. Using cell lines expressing comparable numbers of either wild-type receptor (EGFRwt) or EGFRvIII, we compared several parameters of receptor activation: dimerization, tyrosine phosphorylation and activation of intracellular signalling proteins. Like activated EGFRwt, EGFRvIII was phosphorylated and bound constitutively to the Shc adapter protein. Indeed, EGFRvIII-associated Shc had a higher phosphotyrosine content than Shc associated with stimulated EGFRwt. EGFRwt dimerized in response to either EGF or transforming growth factor α. Higher cross-linker concentrations and incubation at higher temperatures (37°C) allowed detection of EGFRwt dimers even in the absence of exogenous ligand. In contrast, EGFRvIII failed to dimerize under any conditions studied. Moreover, neither mitogen-activated protein kinase nor phospholipase Cγ were phosphorylated in EGFRvIII-expressing cells. We conclude that the deletion of 267 amino acids from the 621-amino-acid N-terminal domain of EGFR does not result simply in a constitutively activated receptor, but alters the spectrum of signalling cascades utilized. Furthermore the ligand-independent transforming activity of EGFRvIII is independent of receptor dimerization.

AB - The type-III deletion variant of the epidermal growth factor receptor (EGFRvIII) is frequently found in glioblastomas and other malignant human tumours. Although EGFRvIII confers ligand-independent oncogenic transformation of cell lines, the mechanism by which it promotes aberrant cellular proliferation is unknown. Using cell lines expressing comparable numbers of either wild-type receptor (EGFRwt) or EGFRvIII, we compared several parameters of receptor activation: dimerization, tyrosine phosphorylation and activation of intracellular signalling proteins. Like activated EGFRwt, EGFRvIII was phosphorylated and bound constitutively to the Shc adapter protein. Indeed, EGFRvIII-associated Shc had a higher phosphotyrosine content than Shc associated with stimulated EGFRwt. EGFRwt dimerized in response to either EGF or transforming growth factor α. Higher cross-linker concentrations and incubation at higher temperatures (37°C) allowed detection of EGFRwt dimers even in the absence of exogenous ligand. In contrast, EGFRvIII failed to dimerize under any conditions studied. Moreover, neither mitogen-activated protein kinase nor phospholipase Cγ were phosphorylated in EGFRvIII-expressing cells. We conclude that the deletion of 267 amino acids from the 621-amino-acid N-terminal domain of EGFR does not result simply in a constitutively activated receptor, but alters the spectrum of signalling cascades utilized. Furthermore the ligand-independent transforming activity of EGFRvIII is independent of receptor dimerization.

UR - http://www.scopus.com/inward/record.url?scp=0030787340&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030787340&partnerID=8YFLogxK

U2 - 10.1042/bj3240855

DO - 10.1042/bj3240855

M3 - Article

C2 - 9210410

AN - SCOPUS:0030787340

VL - 324

SP - 855

EP - 861

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 3

ER -